U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Holding

Reuters09-23

Sept 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cardinal Health, Factset and Paylocity Holding on Monday.

HIGHLIGHTS

* Cardinal Health Inc : Baird raises target price to $140 from $137

* Factset : Jefferies raises target price to $486 from $435

* Marinus Pharmaceuticals Inc : Oppenheimer raises to outperform from

perform

* Paylocity Holding Corp : TD Cowen raises target price to $186 from $171

* United Rentals Inc : JP Morgan raises target price to $940 from $780

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* America'S Car-Mart Inc : Jefferies cuts target price to $45 from $68

* Apellis Pharmaceuticals Inc : Baird cuts target price to $92 from $96

* Cardinal Health Inc : Baird raises target price to $140 from $137

* Corbus Pharmaceuticals Holdings Inc : B. Riley cuts PT to $40 from $85

* Factset : Jefferies raises target price to $486 from $435

* Ford Motor Co : HSBC cuts target price to $12.5 from $13

* GE Vernova Inc : Jefferies raises target price to $293 from $261

* General Motors : HSBC raises target price to $58 from $56

* Kenvue Inc : Piper Sandler raises target price to $21 from $20

* Lennar Corp : Barclays raises target price to $210 from $177

* Lennar Corp : JP Morgan raises target price to $173 from $154

* Lennar Corp : Wedbush raises target price to $164 from $144

* Marinus Pharmaceuticals Inc : Oppenheimer raises to outperform from perform

* Millerknoll Inc : Craig-Hallum cuts target price to $28 from $30

* Paycor HCM Inc : TD Cowen raises target price to $15 from $14

* Paylocity Holding Corp : TD Cowen raises target price to $186 from $171

* Roblox Corp : Jefferies raises target price to $44 from $42

* Trinet Group Inc : TD Cowen cuts target price to $110 from $123

* United Rentals Inc : JP Morgan raises target price to $940 from $780

* United Therapeutics Corp : Jefferies assumes coverage With Buy rating

* United Therapeutics Corp : Jefferies assumes coverage With target price $432

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment